We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
CTOR

Price
1.13
Stock movement down
-0.03 (-2.59%)
Company name
Citius Oncology, Inc.
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
94.37M
Ent value
153.68M
Price/Sales
-
Price/Book
2.91
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-21.53%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-12-10

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

CTOR does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF214748.36
Price to FCF214748.36
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book2.91
EV to Sales-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count83.51M
EPS (TTM)-
FCF per share (TTM)-

Income statement

Loading...
Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)-0.14

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash112.00
Net receivables0.00
Total current assets18.31M
Goodwill0.00
Intangible assets73.40M
Property, plant and equipment0.00
Total assets91.71M
Accounts payable8.67M
Short/Current long term debt3.80M
Total current liabilities52.99M
Total liabilities59.31M
Shareholder's equity32.40M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open1.16
Daily high1.20
Daily low1.09
Daily Volume241K
All-time high5.29
1y analyst estimate6.00
Beta2.90
EPS (TTM)-
Dividend per share0.00
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
CTORS&P500
Current price drop from All-time high-78.64%-
Highest price drop-82.16%-19.00%
Date of highest drop18 Mar 20258 Apr 2025
Avg drop from high-65.09%-2.66%
Avg time to new high59 days6 days
Max time to new high177 days89 days

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
CTOR (Citius Oncology, Inc.) company logo
Marketcap
94.37M
Marketcap category
Small-cap
Description
Citius Oncology, Inc. focuses on the development and commercialization of innovative targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. is a subsidiary of Leonard-Meron Biosciences, Inc.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner